Ignite Creation Date:
2025-12-24 @ 7:00 PM
Ignite Modification Date:
2026-01-02 @ 2:14 PM
Study NCT ID:
NCT05110157
Status:
COMPLETED
Last Update Posted:
2025-07-10
First Post:
2021-10-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Journey Study: Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as Adjunctive Treatment for Schizophrenia
Sponsor:
Neurocrine Biosciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-11-29
Start Date Type:
ACTUAL
Primary Completion Date:
2025-02-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-02-18
Completion Date Type:
ACTUAL
First Submit Date:
2021-10-26
First Submit QC Date:
None
Study First Post Date:
2021-11-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-09
Last Update Post Date:
2025-07-10
Last Update Post Date Type:
ACTUAL